Concepedia

Denys Pominchuk

DP

2

Publications

80

Citations

2

H-Index

2023

Active since

Affiliations

Azienda USL di Bologna(Current)

Kyiv City Clinical Oncology Center

Sarah Cannon

Pyatigorsk Oncology Center

Uzhhorod National University

Denys Pominchuk is an author at Azienda USL di Bologna specializing in cancer therapeutics, cancer research, and breast cancer.

Top concepts

Publications per year

2023–2024

2

Publications

2

Camizestrant, a next-generation oral SERD, versus fulvestrant in post-menopausal women with oestrogen receptor-positive, HER2-negative advanced breast cancer (SERENA-2): a multi-dose, open-label, randomised, phase 2 trial

Mafalda Oliveira, Denys Pominchuk, Zbigniew Nowecki et al. · The Lancet Oncology · 2024 · 61 citations

, , +12

Clinical activity of camizestrant, a next-generation SERD, versus fulvestrant in patients with a detectable <i>ESR1</i> mutation: Exploratory analysis of the SERENA-2 phase 2 trial.

Mafalda Oliveira, Denys Pominchuk, Erika Hamilton et al. · Journal of Clinical Oncology · 2023 · 19 citations

, , +26

Rows per page

1–2 of 2